India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
At what age should lab tests be done? Rather than treating the disease after it occurs, true health awareness is to detect the disease before it occurs. Blood tests play an important role in this. At what age should lab tests be done? Modern lifestyles are increasing silent diseases such as diabetes , high blood pressure , and liver problems due to physical inactivity and unbalanced diet. The World Health Organization has said that regular health check-ups are necessary even before the disease occurs and has called lab tests an 'alarm system'. There is a medical recommendation that high-risk groups should undergo regular lab tests from the age of 20 to 25 and the general public from the age of 40 to 45. Today's lifestyle. There are many 'conveniences'. You don't have to walk long distances to go anywhere. Vehicles deliver to your doorstep. You don't have to wash your clothes yourself, if you don't have a washing machine at home, there are dry cleaners ...